英文名稱 |
中文名稱 |
CAS號 |
操作 |
(Rac)-BAY1238097 |
(RAC)-BAY1238097 |
1564268-19-4 |
詳細(xì)
|
GSK1379725A |
1802251-00-8 |
1802251-00-8 |
詳細(xì)
|
Sirt2-IN-1 |
SIRT2-IN-1 |
1862238-00-3 |
詳細(xì)
|
HJB97 |
|
2093391-24-1 |
詳細(xì)
|
INCB054329 |
1628607-64-6 |
1628607-64-6 |
詳細(xì)
|
CF53 |
CF53 |
1808160-52-2 |
詳細(xì)
|
TCS 21311 |
TCS21311; TCS-21311 |
1260181-14-3 |
詳細(xì)
|
GNE-049 |
化合物 T15397 |
1936421-41-8 |
詳細(xì)
|
DCP-LA |
DCP-LA |
28399-31-7 |
詳細(xì)
|
DCPLA-ME |
DCPLA-ME |
56687-67-3 |
詳細(xì)
|
EB-47 dihydrochloride |
EB47; EB-47 |
1190332-25-2 |
詳細(xì)
|
BYK204165 |
4-((1-甲基-1H-吡咯-2-基)亞甲基)異喹啉-1,3(2H,4H)-二酮 |
1104546-89-5 |
詳細(xì)
|
GNE-781 |
GNE-781 |
1936422-33-1 |
詳細(xì)
|
GeA-69 |
N-(2-(9H-咔唑-1-基)苯基)乙酰胺 |
2143475-98-1 |
詳細(xì)
|
JFD00244 |
JFD00244 |
96969-83-4 |
詳細(xì)
|
Valemetostat tosylate |
VALEMETOSTAT TOSYLATE |
1809336-93-3 |
詳細(xì)
|
UNC0224 |
UNC 0224 |
1197196-48-7 |
詳細(xì)
|
UNC0321 |
UNC0321 |
1238673-32-9 |
詳細(xì)
|
EZM 2302 |
GSK 3359088 |
1628830-21-6 |
詳細(xì)
|
E-7386 |
E-7386 |
1799824-08-0 |
詳細(xì)
|
EBI-2511 |
化合物EBI-2511 |
2098546-05-3 |
詳細(xì)
|
CBP/EP300-IN-1 |
Benzoic acid, 3-[[(1-acetyl-5-methoxy-1H-indol-3-yl)carbonyl]amino]-4-fluoro-, 1,1-dimethylethyl ester |
2443789-32-8 |
詳細(xì)
|
Y06036 |
Y06036 |
1832671-96-1 |
詳細(xì)
|
Y06137 |
Y06137 |
2226534-49-0 |
詳細(xì)
|
EHMT2-IN-2 |
EHMT2-IN-2 |
2230850-47-0 |
詳細(xì)
|
BRD7-IN-1 |
化合物BRD7-IN-1 |
2448414-48-8 |
詳細(xì)
|
MT1 |
MT1 BET INHIBITOR |
2060573-82-0 |
詳細(xì)
|
ZL0420 |
ZL0420 |
2230496-80-5 |
詳細(xì)
|
NCGC00247743 |
1435192-04-3 |
1435192-04-3 |
詳細(xì)
|
BAY1238097 |
BAY1238097 |
1564268-08-1 |
詳細(xì)
|
(R)-BAY1238097 |
(R)-BAY1238097 |
1564269-85-7 |
詳細(xì)
|
BET bromodomain inhibitor |
化合物BET BROMODOMAIN INHIBITOR |
1505453-59-7 |
詳細(xì)
|
CMPD101 |
CMPD101 |
865608-11-3 |
詳細(xì)
|
T-3775440 hydrochloride |
T-3775440鹽酸鹽 |
1422535-52-1 |
詳細(xì)
|
Fasudil Hydrochloride |
鹽酸法舒地爾 |
105628-07-7 |
詳細(xì)
|
PROTAC Sirt2 Degrader-1 |
2MG |
2098487-75-1 |
詳細(xì)
|
PF-06726304 |
PF-06726304 |
1616287-82-1 |
詳細(xì)
|
Seclidemstat |
SECLIDEMSTAT |
1423715-37-0 |
詳細(xì)
|
GSK2807 Trifluoroacetate |
GSK2807 Trifluoroacetate |
2245255-66-5 |
詳細(xì)
|
QC6352 |
QC6352 |
1851373-36-8 |
詳細(xì)
|
CAY10602 |
1-(4-氟苯基)-3-(苯磺?;?-1H-吡咯并[2,3-B]喹喔啉-2-胺 |
374922-43-7 |
詳細(xì)
|
SRT 1720 |
N-[2-[3-(1-哌嗪基甲基)咪唑并[2,1-B]噻唑-6-基]苯基]-2-喹喔啉甲酰胺 |
925434-55-5 |
詳細(xì)
|
Niraparib hydrochloride |
MK-4827 |
1038915-64-8 |
詳細(xì)
|
Niraparib (R-enantiomer) |
MK-4827 (R-enantioMer) |
1038915-58-0 |
詳細(xì)
|
Delcasertib |
Delcasertib |
949100-39-4 |
詳細(xì)
|
SB-218078 |
SB218078 |
135897-06-2 |
詳細(xì)
|
BAY-299 |
BAY-299 |
2080306-23-4 |
詳細(xì)
|
GSK8573 |
GSK8573 |
1693766-04-9 |
詳細(xì)
|
R 59-022 |
化合物 T16709 |
93076-89-2 |
詳細(xì)
|
Bisindolylmaleimide X hydrochloride |
BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE) |
145317-11-9 |
詳細(xì)
|
SIRT5 inhibitor 1 |
2166487-21-2 |
2166487-21-2 |
詳細(xì)
|
PKC-theta inhibitor |
MDK-8650 |
736048-65-0 |
詳細(xì)
|
SGC-iMLLT |
SGC-IMLLT |
2255338-25-9 |
詳細(xì)
|
Nudifloramide |
1-甲基-6-氧代吡啶-3-甲酰胺 |
701-44-0 |
詳細(xì)
|
BI-9321 trihydrochloride |
BI-9321 trihydrochloride |
2387510-87-2 |
詳細(xì)
|
MRK-740 |
化合物 MRK-740 |
2387510-80-5 |
詳細(xì)
|
UBCS039 |
UBCS039 |
358721-70-7 |
詳細(xì)
|
PIN1 inhibitor API-1 |
O6-[4-(TRIFLUOROACETAMIDOMETHYL)BENZYL]GUANINE |
680622-70-2 |
詳細(xì)
|
GSK467 |
化合物GSK467 |
1628332-52-4 |
詳細(xì)
|
(S)-JQ-35 |
1349719-98-7 |
1349719-98-7 |
詳細(xì)
|
BJE6-106 |
BJE6-106 |
1564249-38-2 |
詳細(xì)
|
PARP14 inhibitor H10 |
PARP14 INHIBITOR H10 |
2084811-68-5 |
詳細(xì)
|
MS402 |
MS-402 |
1672684-68-2 |
詳細(xì)
|
GNE-207 |
化合物 T15399 |
2158266-58-9 |
詳細(xì)
|
CMP-5 |
1-(9-ethyl-9H-carbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine |
880813-42-3 |
詳細(xì)
|
KDM5-C70 |
ethyl 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinate |
1596348-32-1 |
詳細(xì)
|
MM-102 TFA |
1883545-52-5 |
1883545-52-5 |
詳細(xì)
|
T-448 |
T-448 |
1597426-53-3 |
詳細(xì)
|
Nicotinamide riboside chloride |
煙酰胺核苷 |
23111-00-4 |
詳細(xì)
|
(-)-Indolactam V |
吲哚內(nèi)酰胺 V |
90365-57-4 |
詳細(xì)
|
UNC0379 TFA |
UNC-0379 TRIFLUOROACETATE |
1620401-83-3 |
詳細(xì)
|
TPPB |
TPPB |
497259-23-1 |
詳細(xì)
|
LIN28 inhibitor LI71 |
LIN28 INHIBITOR LI71 |
1357248-83-9 |
詳細(xì)
|
ζ-Stat |
8-羥基-1,3,6-萘三磺酸 |
3316-02-7 |
詳細(xì)
|
ζ-Stat trisodium |
8-羥基-1,3,6-萘三磺酸三鈉鹽 |
31894-34-5 |
詳細(xì)
|
GNA002 |
GNA002 |
1385035-79-9 |
詳細(xì)
|
A-395 |
化合物A-395 |
2089148-72-9 |
詳細(xì)
|
JNJ-64619178 |
CS-2829 |
2086772-26-9 |
詳細(xì)
|
IACS-9571 hydrochloride |
IACS-9571 hydrochloride |
2319611-93-1 |
詳細(xì)
|
MOZ-IN-2 |
MOZ-IN-2 |
2055397-88-9 |
詳細(xì)
|
HA-100 |
1-(5-異喹啉磺?;?哌嗪鹽酸鹽 |
84468-24-6 |
詳細(xì)
|
GSK 4027 |
化合物 T11495L |
2079896-25-4 |
詳細(xì)
|
GSK4028 |
2079886-19-2 |
2079886-19-2 |
詳細(xì)
|
D-erythro-Sphingosine |
D-鞘氨醇 |
123-78-4 |
詳細(xì)
|
PBIT |
2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one |
2514-30-9 |
詳細(xì)
|
AK-1 |
SIRT2 Inhibitor II, AK-1 |
330461-64-8 |
詳細(xì)
|
p32 Inhibitor M36 |
P32 INHIBITOR M36 (M36) |
802555-85-7 |
詳細(xì)
|
CTPB |
CTPB |
586976-24-1 |
詳細(xì)
|
SRT 1460 |
3,4,5-三甲氧基-N-(2-(3-(哌嗪-1-基甲基)咪唑并[2,1-B]噻唑-6-基)苯基)苯甲酰胺 |
925432-73-1 |
詳細(xì)
|
DS-437 |
DS-437 |
1674364-87-4 |
詳細(xì)
|
BET-BAY 002 |
1588521-78-1 |
1588521-78-1 |
詳細(xì)
|
GSK9311 |
1923851-49-3 |
1923851-49-3 |
詳細(xì)
|
Histone Acetyltransferase Inhibitor II |
組蛋白乙酰轉(zhuǎn)移酶 抑制劑II |
932749-62-7 |
詳細(xì)
|
MS645 |
MS645 |
2250091-96-2 |
詳細(xì)
|
A-3 hydrochloride |
赤霉酸 |
78957-85-4 |
詳細(xì)
|
PKC-iota inhibitor 1 |
2-氨基-5-(3-(哌嗪-1-基)苯基)-N-(吡啶-4-基)煙酰胺 |
2328094-11-5 |
詳細(xì)
|
DC_517 |
CS-2082 |
500017-70-9 |
詳細(xì)
|
CARM1-IN-1 |
1020399-49-8 |
1020399-49-8 |
詳細(xì)
|
CARM1-IN-1 hydrochloride |
CARM1-IN-1 (hydrochloride) |
2070018-31-2 |
詳細(xì)
|
ORY-1001(trans) |
1431303-72-8 |
1431303-72-8 |
詳細(xì)
|